Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes: A Meta-Analysis

JACC Heart Fail. 2016 Nov;4(11):910. doi: 10.1016/j.jchf.2016.07.005.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Dipeptidyl-Peptidase IV Inhibitors
  • Heart Failure
  • Humans
  • Pyrazines
  • Risk
  • Sitagliptin Phosphate*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Pyrazines
  • Sitagliptin Phosphate